IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
Idoven has raised €22M across 5 funding rounds from 12 investors, most recently a round in Sep 2023. Based in Madrid, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2023-09-05 | Other | — | Adam Chekroud,Hambro Perks,Insight Partners,Luis Sanz,Northzone,Pau Gasol | View deal → |
| 2023-07-31 | Other | €1.5M | EIT Health | View deal → |
| 2022-06-22 | Other | €19M | Diego Piacentini,Iker Casillas,Insight Partners,Northzone,Sebastian Gunningham,Wayra | View deal → |
| 2021-05-27 | Other | €2.0M | Accel,Wayra | View deal → |
| 2020-06-05 | Other | €0 | — | View deal → |
